In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
The Cancer Research Institute is committing $2.5 million in reserve funding to support an additional postdoctoral fellowships in the face of federal instability.
The Stephenson Global Pancreatic Cancer Research Institute, established to advance early detection, innovative treatments, and groundbreaking research for pancreatic cancer, has launched a call for nominations and Letters of Intent for two award opportunities.
Global research initiative Cancer Grand Challenges announced on March 5 seven new challenges which it deems to be among the biggest questions in cancer, offering international researchers the chance to form teams to apply for up to $25 million (or £20 million) in funding to take them on.
The FY25 Defense Appropriations Act is anticipated to provide funding for the Peer Reviewed Cancer Research Program to support innovative, high-impact cancer research.
The FY25 Defense Appropriations Act is anticipated to provide funding for the Melanoma Research Program to support innovative, high-impact melanoma research.
The governing body of the Cancer Prevention and Research Institute of Texas approved 53 grants totaling more than $67 million to state research institutions to advance the state’s fight against cancer. The grants provide funding for a wide array of cancer projects, including CPRIT Scholar recruitment awards, funding for collaborative core facilities, and support for cancer clinical trials.
In this episode of In the Headlines, Paul Goldberg, publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, discuss the “doomsday scenario” facing academic cancer centers that would follow the success of President Trump’s move to limit indirect costs to 15% for NIH-funded institutions.
A federal judge in Massachusetts on Feb. 10, issued a preliminary restraining order, blocking the Trump administration from enforcing an NIH guidance that would cut the indirect costs paid on NIH grants to a flat rate of 15%.
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from NIH to support the Neuro-Oncology Translational Research Training Program, an initiative designed to train the next generation of brain tumor scientists and physician-scientists.
